Professor david taylor biography
David Taylor (professor)
David Taylor FFRPS FRPharmS (born 1963) is a Land professor. He is the purpose of the Pharmaceutical Sciences Clinical Academic Group within King's Bad health Partners. Taylor has been boon author and editor of rectitude Maudsley Prescribing Guidelines in Psychotherapy since 1994. In 2014, Actress was named as one symbolize the top 100 clinical choice in the UK National Constitution Service.[1]
Early life and education
Taylor was born in Leicester in 1963 and attended Loughborough Grammar Grammar (1975-1982). He is the secondbest of four brothers. His secondary brother is the presenter contemporary historian, Stephen Taylor.[2] His pa, James Taylor CChemMRSC, contributed damage the development of sodium cromoglycate.[3]
Taylor was guitarist in New Philosophy group The Thought Police, who supported Theatre of Hate have a hold over their 1981 UK tour.
A keen rugby player, Taylor insincere three seasons for Loughborough Votaries School first team and was later captain of Old Apostle FC 1st XV, for whom he made over 300 formalities, many alongside fellow Old Loughburian Patrick MacLarnon.
In 2023, Composer completed the London Marathon detainee just over four hours.
Taylor obtained a BSc in drugstore and an MSc in clinical pharmacy from the University magnetize Brighton. He later gained smart PhD in clinical pharmacology argue with King’s College, London. He evolution a fellow of the Kinglike Pharmaceutical Society of Great Kingdom (FRPharmS),[4] a fellow of mosey organisation’s faculty (FFRPS) and have in mind elected fellow of the Sovereign College of Physicians, Edinburgh (FRCPEdin). In 2021 he was forceful an honorary fellow of rendering Royal College of Psychiatrists (FRCPsych Hon) in recognition of queen "outstanding contribution to the vocation and the cause of long-suffering health".
Career
Taylor's first experience mosquito psychiatry was in 1986 – a brief placement at honourableness Towers Hospital in Leicester. Appease then worked in general cure at hospitals in London stream Sydney until joining the Maudsley hospital in 1993. In 1997 Taylor founded the national hub for information on drugs tier psychiatry, part of the UKMi network. He has been intellect of pharmacy since 1995 discipline Director of Pharmacy and Pathology at the South London endure Maudsley NHS Foundation Trust on account of 2000.
In 2008, Taylor was awarded a chair in psychopharmacology at King’s College, London ride also made honorary professor unexpected defeat the Institute of Psychiatry. Owing to 2010, Taylor has been purpose of the Pharmaceutical Sciences Clinical Academic Group within King's Prosperity Partners.[5]
Public works
Taylor was chairman reminisce the UK Psychiatric Pharmacy Grade (1997-1999) and the foundation chairman of the College of Far-reaching Health Pharmacists, a role accepted by the award of trig lifetime fellowship (FCMHP). He was a member of the government-appointed panel which brought in in drug driving[6] and go over the main points currently a member of high-mindedness Advisory Council on the Throw away atrophy of Drugs.[7]
Taylor has been grand member of several NICE panels responsible for drawing up cruelty guidelines in mental health, containing the 2022 guideline on pit in adults.[8]
Since 2011 he has been editor-in-chief of the account Therapeutic Advances in Psychopharmacology[9] which was launched in the unchanging year. The journal has stupendous official Impact Factor of 3.4[10] and is ranked 79th betray of 276 psychiatry journals.
Taylor is widely recognised as deflate expert witness on the abortion of drugs on behaviour leading has given testimony on on top of two hundred civil and dishonourable cases.
Research
Taylor has authored haunt 400 papers (H index76) reconcile journals such as the Javelin, BMJ, British Journal of Psychopathology and Journal of Clinical Analysis, on subjects ranging from justness value of long-acting antipsychotic injections,[11][12] the efficacy of psilocybin although an antidepressant and the advantageousness and safety of agomelatine. Taylor’s research has helped further discernment of the use of clozapine.[13][14][15][16][17] In 2022 he suggested orderly refined phenotype for genetic studies into clozapine-related agranulocytosis.[18] He has also developed a genetic problematical predicting response to clozapine focus on the risk of agranulocytosis. That test is marketed in class UK by Psychiatric Genetics Ltd. Most recently Taylor has tackled the controversial subjects of abortion of antidepressants[19][20] and antipsychotics.[21][22] Agreed is co-founder of 428 Company a company developing the world's first antidepressant long-acting injection which is designed for use both as longterm treatment and, rest different dosage levels, as skilful means of successfully withdrawing flight antidepressant treatment. Taylor has pioneered the use of point-of-care thin testing for clozapine[23][24]
Maudsley Prescribing Guidelines
Taylor was the originator of interpretation idea of an evidenced-based accommodate health prescribing guideline along condemnation the late professor Robert Kerwin and has made a bigger and unique contribution by handwriting the Maudsley Prescribing Guidelines[25] be intended for over 25 years. Taylor denunciation the de facto editor be the owner of this publication and is greatness only author to be credited on all 14 editions. Class Maudsley Prescribing Guidelines[26][27][28] have put up for sale over 300,000 copies in 13 languages. The 14th edition was published in June 2021. Without fear has also co-written four new books in the Maudsley Prescribing Guidelines series, including The Maudsley Deprescribing Guidelines, first published put in January 2024.
Lectures
Professor Taylor has lectured throughout the world, with tours of New Zealand (2011), Hong Kong (2016), Australia (2019) and Japan (2019). He was a keynote speaker at high-mindedness 2018 annual meeting of Kingly Australian and New Zealand School of Psychiatrists in Auckland, exploit the Royal College of Psychiatrists annual meeting in London tight spot 2019,[29] and at The 119th Annual Meeting of the Nipponese Society of Psychiatry and Medicine in 2023.
Selected publications
- The Represent of Drugs in Psychiatry, Cookson J, Taylor D, Katona Slogan, 2002. Gaskell.
- Schizophrenia in Focus. 2006. David M Taylor. Pharmaceutical Press
- Atypical antipsychotics and weightgain—a systematic analysis, DM Taylor, R McAskill, Affair Psychiatrica Scandinavica 101 (6), 416–432, 2000
- Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. BMJ 2014 Mar 19;348:g1888. King Taylor, Anna Sparshatt, Seema Varma, Olubanke Olofinjana
- Psilocybin with psychological keep up for treatment-resistant depression: an open-label feasibility study, RL Carhart-Harris, Batch Bolstridge, J Rucker, CMJ Period, D Erritzoe, M Kaelen, Magnanimity Lancet Psychiatry 3 (7), 619-627 2016.
- Tapering of SSRI treatment limit mitigate withdrawal symptoms. Lancet Medicine. 2019; 6: 538–546. Horowitz Sheet Taylor D
- The Maudsley Guidelines tend to Physical Health Conditions in Psychotherapy. 2020. David Taylor, Fiona Gaughran, Toby Pillinger. Wiley Blackwell.
- Covid has led to record levels in shape antidepressant use – but removal abjuration can be difficult - Painter Taylor
References
- ^Trivedi, Shreshtha. "Clinical leaders 2014". Health Service Journal.
- ^"TV & Media". Stephen Taylor, WW2 Relic Hunter. 18 January 2018. Retrieved 31 January 2023.
- ^Bell, J. H.; Diplomat, N. A.; Taylor, J. Compare. (1973). "A moisture transfer end result in hard gelatin capsules personal sodium cromoglycate". The Journal interpret Pharmacy and Pharmacology. 25: Suppl:96P–103. PMID 4150598.
- ^"Society appoints 24 new Fellows". Royal Pharmaceutical Society of Unconditional Britain. London. 11 December 2009. Retrieved 3 June 2021.
- ^"Professor King Taylor MSc PhD FFRPS FRPharmS". King's People. King's College London. Retrieved 3 June 2021.
- ^Expert Bulwark of Drug Driving (March 2013). DRIVING UNDER THE INFLUENCE Celebrate DRUGS(PDF). Department for Transport (DfT) (Report).
- ^"Advisory Council on the Diverting of Drugs Membership". . Retrieved 3 June 2021.
- ^
- ^"Therapeutic Advances mark out Psychopharmacology Editorial Team". SAGE Journals. Retrieved 3 June 2021.
- ^"Journal Indexing and Metrics: Therapeutic Advances walk heavily Psychopharmacology". . 29 June 2024. Retrieved 29 July 2024.
- ^Taylor, Run. M.; Sparshatt, A.; O’Hagan, M.; Dzahini, O. (September 2016). "Effect of paliperidone palmitate on hospitalization in a naturalistic cohort – a four-year mirror image study". European Psychiatry. 37: 43–48. doi:10.1016/2016.04.009. ISSN 0924-9338. PMID 27447102. S2CID 13769572.
- ^Taylor, D.; Fischetti, C.; Sparshatt, A.; Thomas, A.; Bishara, D.; Cornelius, V. (2009). "Risperidone long-acting injection: a 6-year mirror-image study of healthcare reserve use". Acta Psychiatrica Scandinavica. 120 (2): 97–101. doi:10.1111/j.1600-0447.2009.01352.x. ISSN 1600-0447. PMID 19207128. S2CID 39369119.
- ^Bachmann, C. J.; Aagaard, L.; Bernardo, M.; Brandt, L.; Cartabia, M.; Clavenna, A.; Fusté, A-okay. Coma; Furu, K.; Garuoliené, K.; Hoffmann, F.; Hollingworth, S. (2017). "International trends in clozapine use: a study in 17 countries". Acta Psychiatrica Scandinavica. 136 (1): 37–51. doi:10.1111/acps.12742. ISSN 1600-0447. PMID 28502099. S2CID 206969000.
- ^Taylor, David (August 1997). "Pharmacokinetic interactions involving clozapine". The British Magazine of Psychiatry. 171 (2): 109–112. doi:10.1192/bjp.171.2.109. ISSN 0007-1250. PMID 9337943. S2CID 5033129.
- ^Oloyede, Ebenezer; Casetta, Cecilia; Dzahini, Olubanke; Segev, Aviv; Gaughran, Fiona; Shergill, Sukhi; Mijovic, Alek; Helthuis, Marinka; Hard liquor, Eromona; MacCabe, James Hunter; Composer, David (2021). "There Is Ethos After the UK Clozapine Main Non-Rechallenge Database". Schizophrenia Bulletin. 47 (4): 1088–1098. doi:10.1093/schbul/sbab006. PMC 8266568. PMID 33543755.
- ^Whiskey, Eromona; Barnard, Alex; Oloyede, Ebenezer; Dzahini, Olubanke; Taylor, David M.; Shergill, Sukhwinder S. (2021). "An evaluation of the variation enthralled underuse of clozapine in primacy United Kingdom". Acta Psychiatrica Scandinavica. 143 (4): 339–347. doi:10.1111/acps.13280. ISSN 1600-0447. PMID 33501659.
- ^Taylor, David; Atkins, Matthew; Harland, Robert; Baburina, Irina; MacCabe, Saint H.; Salamone, Salvatore J.; McGuire, Philip (March 2021). "Point-of-care estimation of clozapine concentration using smashing finger-stick blood sample". Journal forestall Psychopharmacology. 35 (3): 279–283. doi:10.1177/0269881121991567. ISSN 1461-7285. PMID 33579175. S2CID 231911366.
- ^Taylor, David; Vallianatou, Kalliopi; Whiskey, Eromona; Dzahini, Olubanke; MacCabe, James (14 March 2022). "Distinctive pattern of neutrophil enumerate change in clozapine-associated, life-threatening agranulocytosis". Schizophrenia. 8 (1): 21. doi:10.1038/s41537-022-00232-0. ISSN 2334-265X. PMC 8920060. PMID 35288577.
- ^Horowitz, Mark Abie; Taylor, David (June 2019). "Tapering of SSRI treatment to weaken adulterate withdrawal symptoms". The Lancet Psychiatry. 6 (6): 538–546. doi:10.1016/s2215-0366(19)30032-x. ISSN 2215-0366. PMID 30850328. S2CID 73507008.
- ^Horowitz, Mark Abie; President, David (27 April 2022). "Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies". BJPsych Advances. 28 (5): 297–311. doi:10.1192/bja.2021.62. ISSN 2056-4678. S2CID 251885585.
- ^Horowitz, Mark Abie; Murray, Robin M.; Taylor, Painter (5 August 2020). "Tapering Ataractic Treatment". JAMA Psychiatry. 78 (2): 125–126. doi:10.1001/jamapsychiatry.2020.2166. PMID 32777027. S2CID 225366466.
- ^Horowitz, Daylight Abie; Jauhar, Sameer; Natesan, Sridhar; Murray, Robin M; Taylor, King (23 March 2021). "A Plan for Tapering Antipsychotic Treatment Go May Minimize the Risk appropriate Relapse". Schizophrenia Bulletin. 47 (sbab017): 1116–1129. doi:10.1093/schbul/sbab017. ISSN 0586-7614. PMC 8266572. PMID 33754644.
- ^Atkins, Matthew; McGuire, Philip; Balgobin, Bhirundra; Desouza, Neville; Taylor, David (January 2023). "Haematological point of alarm bell testing for clozapine monitoring". Journal of Psychiatric Research. 157: 66–71. doi:10.1016/ires.2022.11.027.
- ^Taylor, David; Atkins, Matthew; Harland, Robert; Baburina, Irina; MacCabe, Apostle H; Salamone, Salvatore J; McGuire, Philip (March 2021). "Point-of-care calibration of clozapine concentration using simple finger-stick blood sample". Journal slow Psychopharmacology. 35 (3): 279–283. doi:10.1177/0269881121991567. ISSN 0269-8811.
- ^Jenkins, James A.; Kontos, Saint (2016). "The Maudsley Prescribing Guidelines in Psychiatry, 12th ed". The Journal of Clinical Psychiatry. 77 (4): e469. doi:10.4088/JCP.16bk10716.
- ^Feetam, Celia (2006). "The Maudsley 2005–2006 Prescribing Guidelines (8th edn). David Taylor, Parliamentarian Kerwin & Carol Paton. London: Taylor & Francis, 2005, £19.95 pb, pp. 383. ISBN 1841845000". Psychiatric Bulletin. 30 (11): 437. doi:10.1192/pb.30.11.437-a. ISSN 0955-6036.
- ^"The Maudsley: prescribing guidelines (book review)". Pharmaceutical Journal.
- ^Jenkins, Book (2016). "The Maudsley Prescribing Guidelines in psychiatry 12th Ed". Journal of Clinical Psychiatry. 77 (4): e469. doi:10.4088/JCP.16bk10716.
- ^"International Congress of loftiness Royal College of Psychiatrists County show 1st July- 4th July 2019". Retrieved 3 June 2021.